Conquer Cancer through AI. Lunit is a public company that develops medical AI software for cancer screening and treatment.
Funding
Public
Current Stage
$122.54M
Recent Funding
$560.73M
Total Funding
Recent News
Leica, Indica Labs and Lunit team up as AI biomarker scoring moves toward clinical scale
Research & Development World
Lunit Expands US AI Adoption and Secures New FDA Clearance
startupresearcher.com
Lunit Cancer Screening · 4w ago
(Global) Director, Clinical Deployment & Growth - Lunit SCOPE
United StatesRemoteDirector/Executive
Lunit Cancer Screening · 1m ago
(Global) Director, Clinical Deployment & Growth - Lunit SCOPE
United StatesRemoteDirector/Executive
Lunit Cancer Screening · 1m ago
(Global) Director, Clinical Deployment & Growth - Lunit SCOPE
United StatesRemoteDirector/Executive
Lunit Cancer Screening · 1m ago
(Global) Director, Clinical Deployment & Growth - Lunit SCOPE
United StatesRemoteDirector/Executive
Lunit Cancer Screening · 1m ago
(Global) Director, Clinical Deployment & Growth - Lunit SCOPE
United StatesRemoteDirector/Executive